Xenograft with or Without Erythropoietin in Immediate Dental Implant
NCT ID: NCT06601400
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
24 participants
INTERVENTIONAL
2024-09-14
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immediate Implant Placement in the Esthetic Zone With and Without Using Autogenous Mixed With Xenograft
NCT04096209
Grafting of the Peri-implant Bony Defects Around Immediate Implants Using Xenogenic Versus Alloplastic Sticky Grafts: Randomized Controlled Clinical Trial
NCT06653868
Immediate Implant Using "Nanobone" Versus "Autogenous Bone" for Treatment of Patients With Unrestorable Single Tooth.
NCT02613663
Zinc Incorporated Bovine Derived- Hydroxyappatite Xenograft in Immediately Placed Implant
NCT07187609
Evaluation of Erythropoietin on Alveolar Ridge Preservation
NCT06513039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Population: Patients with non-restorable tooth in anterior maxilla with thin buccal bone (less than 1mm) Intervention: Immediate implant placement with Xenograft mixed with Erythropoietin.
Control: Immediate implant placement with Xenograft alone.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A (Test)
Immediate implant placement with Xenograft mixed with Erythropoietin
Erythropoietin (EPO) with xenograft
After atraumatic extraction of the non-restorable tooth, Implant will be placed palatal and apical to osteotomy with at least 2mm gap junction between implant and buccal bone which will be grafted with xenograft and erythropoietin.
Group B (Control)
Immediate implant placement with Xenograft alone
Xenograft alone
After atraumatic extraction of the non-restorable tooth, implant will be placed palatal and apical to osteotomy with at least 2mm gap junction between implant and buccal bone which will be grafted with xenograft alone.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Erythropoietin (EPO) with xenograft
After atraumatic extraction of the non-restorable tooth, Implant will be placed palatal and apical to osteotomy with at least 2mm gap junction between implant and buccal bone which will be grafted with xenograft and erythropoietin.
Xenograft alone
After atraumatic extraction of the non-restorable tooth, implant will be placed palatal and apical to osteotomy with at least 2mm gap junction between implant and buccal bone which will be grafted with xenograft alone.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intact with thin labial plate of bone (≤1mm).
* The recipient site of the implant should be free from any pathological conditions.
* Patients who are cooperative, motivated and hygiene conscious.
* Appropriate crown height space to maintain favorable crown : implant ratio
Exclusion Criteria
* Patients who have any habits that might jeopardize the osseointegration process, such as current smokers.
* Patients with parafunctional habits that produce overload on implant, such as bruxism and clenching.
* Patients with periodontal disease.
* Alcohol or drug abuse.
* Pregnant and lactating women.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kholoud Sobhy Ibrahim Farag El Deeb
assistant lecturer at future university in egypt
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Noha ghallab, PHD
Role: STUDY_DIRECTOR
Professor of Oral Medicine and Periodontology, Faculty of Dentistry, Cairo University.
Manar El Zanaty, PHD
Role: STUDY_CHAIR
lecturer of periodontology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of dentistry, Cairo university
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
kholoud Sobhy Eldeeb, Master degree holder
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Fettouh AIA, Ghallab NA, Ghaffar KA, Mina NA, Abdelmalak MS, Abdelrahman AAG, Shemais NM. Bone dimensional changes after flapless immediate implant placement with and without bone grafting: Randomized clinical trial. Clin Implant Dent Relat Res. 2023 Apr;25(2):271-283. doi: 10.1111/cid.13178. Epub 2023 Jan 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Erythropoietin,Dental implant
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.